Effectiveness of adrenal corticosteroids in the management of severe bacterial infections.
D000311:Adrenal Glands / Q000502:physiology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000188:drug therapy*; D001623:Betamethasone / Q000627:therapeutic use; D001929:Brain Edema / Q000188:drug therapy; D002493:Central Nervous System Diseases / Q000188:drug therapy; D004195:Disease Models, Animal; D004357:Drug Synergism; D004731:Endotoxins / Q000037:antagonists & inhibitors; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D008586:Meningitis, Pneumococcal / Q000188:drug therapy; D008775:Methylprednisolone / Q000627:therapeutic use; D011008:Pneumococcal Infections / Q000188:drug therapy; D011014:Pneumonia / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D011817:Rabbits; D018805:Sepsis / Q000188:drug therapy; D013223:Statistics as Topic
D000900:Anti-Bacterial Agents; D004731:Endotoxins; D005938:Glucocorticoids; D001623:Betamethasone; D011241:Prednisone; D006854:Hydrocortisone; D008775:Methylprednisolone